COMPARATIVE STUDY OF ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEIS) FOR BP REDUCTION
Hassah Batool Iftikhar and Jiang Hong, MD*
The National WHO published guidelines in the management of hypertension beyond the approach of cardiovascular risk factors addressing the scheme of ACEI and ARB comparison to requisite the lifestyle modifications in the adherence of efficacy of safety goals. The ascertainment of mono-therapy and combined therapy trial reduced the systolic-diastolic BP statistically in the effectiveness of survival rates at the all-cause cardiac events. Moreover, the symptomatic optimal dosing randomized beneficially in the measurements of highest satisfactory intervention isolatedly arranged the sequence of ascending to descending structure directing the least potency on the pathogenesis of heart failure as the long-term hemodynamic vaso-dilators.
Keywords: Angiotensin Receptor Blockers: Angiotensin Converting Enzyme Inhibitors: Antihypertensive therapy: Clinical Trials: Cardiovascular side effects.
[Full Text Article]